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EDITORIAL 
Fibronectin in the Skin 
The role of fib ronectin in vivo is rapidly becoming better 
defined. The observations by Gibson et al (t his issue) that 
fibronectin in late fetal rat skin is more widespread and often 
more in tense t han in adul t rat skin corresponds nicely with 
previous in vivo reports that fibronectin appears to increase in 
tissues that are undergoing modification whether during em-
bryogenesis [1- 13], inflammation [14-18], tumor growth [19-
21], or wound repair [22-30). Interactions of cells with extra-
cellular matrix are cri t ically important events during t imes of 
t issue reorganization and growth regulation. For example in 
vitro studies have shown t hat t he in teraction of cells with 
purified extracellular molecules such as collagen, fibronectin , 
laminin, and hyaluronic acid can alter t heir capacity to adhere, 
migrate, and proliferate, and can even alter t heir biosynthetic 
patterns and ce llular phenotype. Although difficult to study, 
interactions between cells and extracellular matrix also may be 
important in the maintenance of normal t issue function. Recent 
progress in this entire field has resul ted from the purification 
of extracellular matri x molecules and from attempts to decipher 
these complex biologic events in terms of t he interaction of 
specialized structure/function domains of the matrix molecules 
with various cell types and with other extracellular matrix 
molecules . Thus, to better explain the implications of in vivo 
investigations t hat loca lized fibronectin to specific areas within 
the skin or determined that the deposition of fibronectin 
changed both quantitatively and qualitatively during tissue 
reorganization, a brief overview of in vi t ro studies that have 
delineated synthesis and secretion of fibronectin by various ce ll 
types and defined · the structure/function interrelationship of 
fibronectin with these cells as well as with other extracellular 
matrix molecules will be given. 
Synthesis and Secretion of Fibronectin 
In tissue cul ture, fibronectin is synt hesized and secreted by 
fibroblasts [31-33], monocytes [34,35], endothelia l cells [36-
38], and a variety of epithelial cells [39-46) including human 
keratinocytes [47-50). In addition, liver cells [51,52) as well as 
isolated perfused liver [53) synthesize and secrete fibronectin 
and probably are responsible for the majority of plasma fibro -
nectin. Although some discrepancy ex ists concerning whether 
human keratinocytes can synthesize fibronectin [54], most 
investigators have found fibronectin between keratinocytes and 
the underlying substratum in concent ric arrays of short radial 
fibrils [47- 50,55). These subcellular matrix patterns of fibro-
nectin are reminiscent of those previously demonstrated in 
nonconfluent fibroblast cultures [39], confluent or noncon-
tluent endothelia l cell cul tures [38], and in cul tures of other 
epithelial cell types [39-43). However, if fibroblasts are allowed 
to reach confluence, a massive network of fibrillar fibronectin 
appears [39) that never occurs in either kerat inocyte or endo-
thelial cell cul tures. These in vitro findings have their in vivo 
correlates. In normal skin, fibronectin is deposited discretely 
along t he dermal-epidermal junction by immunofluorescent 
studies [56- 58; Gibson et a l, this issue] and at the basal cell 
plasma membrane and lamina Iucida areas of t he epidermal-
basement membrane by immunoelectron microscopy [58; Gib-
son et a l. , this issue]. In addition, fibronectin is deposited in a 
linear fashion along the walls of blood vessels by immunofluo-
rescence studies [18,26,27,57- 59) and immediately underlying 
the endothelium within t he basement membrane by immunoe-
lectron microscopy [58). In contrast, in t he connective tissue 
of t he dermis, fibro nectin is found deposited as amorphous 
granules, short fibrils, or intensely fluorescent patches [57,58). 
Fibroblasts often are responsible for the intense patches while 
by immunoelectron microscopy collagen fibrils are decorated 
with fibronectin and t hus responsible for the fibr illar pattern 
[58; Gibson et al, this issue). An even stronger in vivo correlate 
fo r the massive network of fibrillar fibronectin in confluent 
fibrob last cul tures is a similar massive network of fib ronectin 
that occurs in t he fibroblast-rich granulation t issue of wound 
repa ir [22,23,26). Thus, the pattern of pericellular matrix fibro-
nectin in cul tures of various cell types is in general similar to 
t he extracellular matrix pattern of fibro nectin found associated 
with the same type of cell s in vivo. 
Stru.ctu.re/ Function Relationships of the Fibronectin Molecu.le 
The morphologic similarities of matrix fibronectin in vitro 
and in vivo gives credence to the fact that interactions of 
fibronectin and cells elucidated in vitro probably have their in 
vivo analogues. In cul ture fibronectin can bind to biologic 
substratum such as collagen or fibrinogen (fibrin ) and simul-
taneously to cell surfaces and t hereby promote attachment 
spreading, and growth of those cells [60- 63). Fibronectin wi ll 
fac ili tate cell attachment to t hese matrices whether derived 
from se rum used in t issue culture medium [61], added in the 
purified state directly to the substratum [62], or synthesized 
and deposited by the cell s in cul ture [63). Fibronectin, which 
is a dimeric 440 kilodalton (kd) glycoprotein , mediates adhesion 
of cell s to substratum by actually cross-linking the cells and 
substratum via specific binding domains that exist along the 
primary structure of each 220 kd chain. These binding domains 
have been elucidated by functional testing of fragments after 
proteolysis of the molecule and by blocking with monoclonal 
ant ibodies t he interaction of fibronectin with either cells or 
wi th other matrix molecules. T hus, each chain of fibronectin 
binds to fibrin or fibrinogen via its amino-terminal domain (a 
27 kd am ino-terminal fibronectin fragment contains this activ-
ity) and through a site near the carboxy terminus of the 
molecule [64- 67], to collagen or ge latin via a 40 kd domain 
near to but not at the amino-terminal end [68-72], and to cell 
surfaces through a 15 kd cell binding site that is approximately 
two-thirds the linear distance toward t he carboxy terminus 
[66,73,74). 
Glycosaminoglycans (GAG), especially heparan sulfates 
which are closely associated with t he ce ll membrane if not 
occasionally intercalated via t heir proteoglycan protein core 
[75], are an addit ional type of binding site on the cell surface 
for fibronectin [76). In vivo these GAG sites are thought to 
stabilize cell -substratum interactions t hat are mediated by fi-
bronectin. Two binding sites exist fo r heparin, the GAG most 
often used for in vit ro studies, a long each chain of fibronectin. 
One site is located in t he am ino-terminal domain of t he mole-
cule [65,67,77,78). The interaction between this site and hepa-
rin is relatively weak as it can be modulated by physiologic 
concentrations of calcium [78], is inhibited by 0.25 M salt 
[77], and, consequent ly, has doubtful biologic significance. A 
second heparin binding site is located close to the carboxyl 
terminus of fibronectin [65,66,77,78). Its binding to heparin is 
less sens itive to salt [77] and is insensitive to divalent cations 
[78). T his second site probably is the biologically significant 
GAG binding domain in vivo. Fibronectin can also bind to the 
GAG, hyaluron ic acid [77-81). However, fibronectin must exist 
as an aggregate in order to bind efficiently to hyaluronic acid. 
T he nonaggregated p lasma fibronectin , derived primarily from 
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hepatocytes [51-53], when coupled to affinity columns binds 
poorly to hyaluronic acid [82]. In cont rast, fibronectin from 
other cell types is normally aggregated and binds to hyaluronic 
acid with moderately high affinity [80] . 
Many of t he interactions between fi bronectin and other 
extracellular matrix molecules can be stabil ized by coagulation 
factor XIII (fibrin-stabilizing factor) . Factor XIII, a t ransglu-
tam inase, enzymatically forms intermolecular ')1-glutaryl-f-ly-
syl covalent bonds between fibronectin and fibrin in clotting 
plasma [83], between fibronectin and collagen [84], and be-
tween two or more fibronectin molecules [85]. F ibronectin 
cross-bonded to fibrin (ogen) by factor XIII provides a much 
more ad hesive surface fo r fi broblasts in vitro t han does fibro-
nectin alone or fibronectin with fibrin(ogen) but without the 
covalent bond [86]. T hus, fibronectin cross-linked by facto r 
XIII to fibrin, to itse lf, or to collagen may be a more stable 
substrate in vivo for cell adhesion, migration, or proliferation. 
Interestingly, the genetic absence of factor XIII is known to be 
associated wit h an incompletely characterized defect in wound 
healing [87]. 
Finally, each subunit of fibronectin contains at least one 
su lfhydryl group [88,89] located -170 kd from t he amino-
terminus and probably a second one furt her toward the carboxyl 
terminus [90]. If these sulfhydryl groups are alkylated, the 
bind ing of fibronectin in to the cell surface matrix is inhibited 
[88,90]. T hus, besides specific domains on each fibronectin 
monomer for cells a nd other extracellular matri x prote ins, 
i" teractions with the GAGs, heparan sulfate, and hyaluronic 
acid, and covalent cross- links mediated either by factor XIII or 
su lfhydryl groups are essent ial for stable fibronectin -mediated 
cell-matrix associations. 
Chemotaxis and Contact Guidance Activity of Fibronectin 
In addit ion to mediating cell adhesion , fibronectin has chem-
otactic properties for several cell types including fi broblasts 
[91], endothelia l cell s [92], and monocytes [93]. This activity 
seems to be located, not surprisingly, near the ce ll binding site 
[94,95]. Fibronectin , however, may also posit ively inf1uence cell 
movement via contact gu idance [96,97] . T he latter mechanism 
involves cells moving along a spec ific substratum that may oi· 
may not be deposited in a gradient fashion. In contrast , chem-
otaxis implies that cell s are sensing a fluid phase gradient and 
moving up that gradient. Thus, fibronectin may mediate cell 
movement through two distinct mechanisms. 
In Vitro and In Vivo Correlates 
T he in vitro data out lined above that fibro nectin is synt he-
sized, secreted, and deposited in the pericellular matrix and 
that once deposited in t he matrix fibronectin can simultane-
ous ly bind other matrix molecules and the ce lls through a 
variety of specific molecular domains, thus correlate nicely wit h 
the in vivo data of Gibson et al and others t hat fibronectin lies 
at the interface between epithe li a l or endothe li a l ce lls and the 
extracell ular matrix, or surrounds fibroblasts as they lie em-
bedded within an extracell ular matrix. Gibson et al's observa-
tion that fibronect in is more intense at t hese sites in rat feta l 
sk in compared to adul t sk in corresponds to findings by others 
that fibronectin appears to be accentuated at sites of tissue 
growth and reo rganization [1-30]. 
Fibronectin in Embryogenesis and Morphogenesis 
Much of t he work demonstrating t he association of fibronec-
t in with migrating and proliferating ce ll populations has come 
from developmenta l biology investigations using immunofluo-
rescence tech niques [1- 13]. Linder et a l [1] were the first to 
demonstrate that fibronectin occurred in various boundary 
membranes such as t he glomerular and tubular basement mem-
branes of the kidney, the boundary membranes of t he notocord, 
yolk sac and vitell ine membranes, and liver sinusoids during 
embryo nic development . They fur t her noted t hat in many 
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instances the expression of fibronectin seemed to be a property 
of primit ive mesenchymal cell s that was acquired ea rly in 
ontogenesis and t hat often terminated during the differentia-
t ion ofthese cells. Critchley et al [2], who studied the deposition 
of fibronectin in the ectoderm of gastrulating chick embryos, 
observed t hat fibronectin was laid down by t he ectoderm, and 
proposed t hat its function was to facilitate certain morphologic 
movements in early development. Thus, a major concept was 
put forth that fibronectin laid down by the ectoderm acts as a 
contact guidance system for primordial germ and mesoderm 
cells. Similar observations have been noted in t he mouse em-
bryo [3] and the sea urchin embryo [5] and have been confirmed 
and extended in the chick embryo [12] . 
Investigations of t he distribut ion of fibronectin during mor-
phogenesis and organogenesis later in embryonic development 
have contri buted support to the hypothesis made by Critc hley 
et a! [2] t hat fibronectin facilitates ce llular movement . For 
instance, fibronectin was detected in t he basement membrane 
of the ectoderm prior to its protrusion into the optic cup to 
form the lens [4]. Similarly, fibronectin occurred t hroughout 
the secondary stroma (but not the primary stroma) t hat lies 
between the ectoderm and the pinched-off lens [4]. T he sec-
ondary, but not primary, stroma supports the invasion of mes-
enchymal cell s which ul t imately deposit extracellular matrix 
material to form the cornea [98]. As the cornea matures and 
condenses from posterior to anterior, fibronectin disappears 
[4]. T hus, in eye development fibronectin occurs at locations 
and at ti mes of cell movement whether t he cells move en masse 
as exemplified by the invagination of the ectoderm to form t he 
lens or singly as exempli fied by mesenchymal invasion of t he 
secondary st roma to ultimately form t he cornea. 
Another instance of an association between matri x fi bronec-
t in and cell movement is embryonic neuralation [12] and sub-
sequent migration of the neural crest cells [6,8,10,11] . In the 
head of a chick embryo ea rly neuralation, t ha t is, t he rounding-
up and invagination of t he ectodermal neural plate into a 
location just under t he ectoderm, followed the deposit ion of a 
fibronectin -rich ectodermal basement membrane [1 2]. Upon 
completion of neuralation, neural crest cell s move out from the 
neural tube as a tongue along t he underside of the fibronectin-
rich ectodermal basement membrane [6]. Later t he crest cell 
population expands into a space away from t he ectoderm . T his 
movement away from t he fi bronectin-rich basemen t membrane 
of t he ectoderm is accompanied by the appearance of fibronec-
t in among t he crest cells [6,8,10]. The en masse movement of 
ce ll s on a fibronectin-rich basement membrane durin g t he 
invagination of the neural tube [6] is reminiscent of the inva-
gination of the lens placode on a fibron~ctin-rich basement 
membrane [4]. Likewise t he outward spread of neural crest 
cells along the fibronectin basement membrane of the ectoderm 
and subsequent ly into a fibronectin-rich ext racellular matrix 
[6,10] is simila r to t he invasion of mesenchymal cells in to the 
fibronectin -rich secondary stroma of nascent cornea [4]. 
Returning to t he skin , fibronectin in the dorsal skin of chick 
embryos is markedly concentrated in areas of t he mesenchyme 
near the dermal-epidermal junction where prospective feather 
t racts are formed by t he condensation of mesenchymal cells 
[7,13]. Interestingly, before t he condensation, type I co llagen 
is seen t hroughout t his upper mesenchyme but di sappears as 
condensation occurs [7,13]. Thus, feather t ract formation has 
three components: di sappearance of type I co llagen, appearance 
of fibronectin , and the locali zation and subsequent migration 
downward of mesenchymal cell s. The invagination of epidermis 
to fo rm feat her rudiments follows with a cont inuing concent ra-
tion of fi bronectin around the follicular dermis and in t he 
dermal core of t he developing feather [13]. Alt hough increased 
amounts of fibronectin seem to occur in the follicular dermis 
around the developing hair shaft in fetal rat skin (F igs 3b and 
4b, Gibson et al, this issue), no increase in fibronectin was 
noted under t he hair germ , the area t hat probably corresponds 
to t he feather t ract in chick embryos. The reason for this 
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difference is not clea r, especia lly since a marked concentration 
of fibronectin occurs around the hair bulbs and is especially 
prominent in hair papillae of adult human skin (persona l 
observations). 
With the knowledge that fibronectin is secreted by many 
cells into the pericellular matrix , that it has t he capacity to 
simultaneous ly bind ce lls and their surrounding or underlying 
matrix , and that it occurs in association with many migrating 
cell populations during early embryogenesis as well as during 
later morphogenesis, the occurrence of fibronectin in the skin 
and its increased concentrations at. sites of inflammation [14-
18], tumor formation [19-21], and wound healing [22-30] is 
not surprising. 
Fibronectin in S l?in I n.flammation 
At. sites of affected skin in psoriasis, fibronectin occurs loca lly 
in the stratum corneum over circumscribed a reas where the 
dermal papillae project up to the stratum corneum [14]. In 
contrast, normal epidermis contains no fibronectin [57,58]. The 
deposition of fibronectin in the stratum corneum suggested 
that it occurred both extracellularly and intracellularly [14]. 
Compared to normal skin, fibronectin at the dermal-epidermal 
junction was normal whereas in elongated papillae fibronectin 
was markedly increased together with an intens ification in the 
microvasculature [14]. In lichen planus [15] and discoid lupus 
[16] lesions, a marked increase in fibronectin was noted at the 
dermal-epidermal junction where basal cell degenerat ion had 
occurred. Once again, fibronectin intensified in the microvas-
culature near lesional skin [15,16] . Fibronectin also increased 
markedly in the involved papillae of dermat itis herpetiformis 
skin lesions [17] . Since fibrin deposit ion occurred in conjunc-
tion with the increased fibronectin , the latter was probably 
plasma derived [17]. The same might be true for fibronect in in 
the dermal papillae of psoriatic lesions and along the dermal -
epidermal junction in lichen planus and lupus although con-
comitant staining was not done for fibrin in these studies. 
In our own studies on the deposit ion of fibronectin at the 
sites of delayed-type hypersensitivity skin reactions [18], we 
observed t hat during the first 2 days after intradermal antigen 
challenge in sensitized guinea pigs, a large quantity of fibro-
nectin appeared as fibrillar strands and minute nodular foci in 
assoc iation with fibrin in the extravascular space. By radiois-
otopic tec hnique t hi s interstitia l accumulation of fibronectin 
was plasma derived [18]. In contrast, fibronectin accumulation 
within blood vessels began 3 days after challenge when inter-
stitia l deposition of plasma fibronectin and fibr in had ceased 
and endothelial cells within the blood vessels at these sites had 
begun to proliferate. From these data, we postulated and later 
confirmed [27] that intravascular fibronectin was produced in 
situ by endothe lial cells. Extrapolating back t.o the sk in disor-
ders listed above, it is likely t hat the increased fibronectin 
noted within the microvasculature near sites of inflammation 
is deposited by activated endothelial cells. Likewise the marked 
increase of fibronectin within the thickened walls of blood 
vessels in sk in of patients with erythropoietic protoporphyria 
[99] is probably secondary to multiple episodes of endotheli al 
cell injury, subsequent activation/proliferation of these cells, 
and a concomitant increased synthesis and deposition of fibro -
nectin by the rejuvenating endothelium. 
Fibronectin in Skin Tu.mors 
Basal cell epithelioma [19,20] and squamous cell carcinoma 
[21] have increased quantities of fibronectin. At first pass this 
increase seems to be in opposition to the extensive studies 
showing that loss of fibronectin is a common, though not 
universal, concomitant of transformation [60,100- 102]. How-
ever, additional studies suggest that a better correlation may 
exist between loss of fibronectin and acqu isition of meta tatic 
Potential [40,103,104]. Since basal cell epithelioma and cuta-
neous squamous cell carcinoma arising in sun -exposed areas 
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have a low metastatic potential, the increase in fibronectin is 
rea lly not discordant with previous work. In basal cell epithe-
lioma fibronectin not only is present within the tumor lobules, 
unlike the normal epidermis where it is absent [57,58], but also 
is markedly increased at t he dermal-epidermal junction and in 
the surrounding stroma [19,20]. This fi nding is actually remi-
niscent of the increase in fibronectin t hat occurs along the 
ectodermal basement membrane just preceding lens invagina-
tion [4] and neura l plate invaginat ion [6]. By electron micros-
copy technique , epithelial cell-substrate adhesion complexes 
have been demonstrated between basal epithelioma cells and 
the underlyi ng basement membrane as well as between human 
squamous carci noma cells and their underlying basement mem-
brane [21 ]. These adhesion complexes (epinexuses) which are 
similar to fibronexuses, previously described for fibroblast-
substrate adhesion complexes [105], seem to replace half-des-
mosomes which occur along t he normal epidermal-dermal junc-
tion [21 ]. The ep inexus is easy to distinguish from a hemides-
mosome since acti n fil aments run into the former [21] while 
tonofilaments slip into the latter. The epinexus, therefore, 
might provide the tracks along which these epidermal tumors 
could invaginate during dermal invasion. 
Fibronectin in Wound Healing 
Finally, wound healing models have provided much infor-
mation regarding associations between fibronectin and migrat-
ing cell populations [22- 30]. Whether full-thickness wounds 
a re made in the skin of guinea pigs [23] or sponges are im -
planted subcutaneously in mice [22], fibronectin appears early 
in granulation t issue formation together with the invading 
fibroblasts [22,23]. Type III and type I collagen appear 2- 7 
days later [22]. As the collagen is organized into larger bundles 
later in wound repair both the fibroblasts and the fibronectin 
di sappear [22]. In our own studies [26], we have noted a striking 
coordinance in 5- to 9-day granulation t issue between the 
reticular deposition of fibronecti n and the disposition of fibro-
blasts. The kinetic and spatial coincidence of fibronectin and 
fibroblasts in wound healing has led us to speculate that a 
functiona l relationship exists between t hese components of 
granulation tissue. Since well-spread fibroblasts in tissue cu l-
ture exhibit a coli near distribut ion of extracellular fibronectin 
fibri ls and in t racellular actin microfilaments [106- 109], bot h 
of which insert at the plasma membrane into a vinculin -
containing plaque [110], t his same colinear distribution was 
sought and found in 7- and 9-day granulation tissue of healing 
excisional wounds in guinea pig skin [29,30]. These findings 
suggest to us that fibronectin attachment to the plasma mem-
branes of fibroblasts causes fibronexus formation and the sub-
sequent generation of prominent acti n microfilament bundles. 
The fibronexus may serve as a microtendon connecting indi -
vidual myofibroblasts of the granulation tissue to each other 
and to the interstitial connective t issue matrix . This fibronectin 
linkage might thereby t ransmit the collective forces generated 
by myofibroblasts t hroughout t he granu lation tissue during 
wound contraction as well as provide a contact guidance system 
for the ingrowt h of fibroblasts. 
Additional investigations have demonstrated t hat fibronectin 
also is markedly accentuated in proliferating blood vessels 
around the perimeter of excisional wounds and in t he neovas-
culature t hat grows into the granulation tissue. Furthermore, 
using a xenograft system and reciprocal species-specific anti-
bodies, the increased blood vessel fibronectin was shown to be 
produced in situ, presumably by proliferating endothelial cells, 
and not to be passively adsorbed from the plasma. In addition, 
fibronectin and fibrin provide a provisional matrix for epider-
mal cell migrat ion during rabbit corneal (24] and guinea pig 
epidermal [25] wound reepit helialization. Once the wound was 
reepit helialized in either system, the subepit helia l fibronectin 
and fibrin progressively disappeared. Using t he same xenograft 
system noted above and reciprocal species-specific antibodies 
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[28], the fibronectin under the migrating epithelium was shown 
to be plasma derived early in reepithelialization (1-4 days) and 
to be both plasma and in situ derived late in reepithelialization 
(4-10 days). Thus, fibronectin may provide a scaffold for epi-
thelial cell and endothelial cell as well as fibroblast migration 
during wound repair. 
In conclusion, much evidence exists that fibronectin is di-
rectly involved in the movement of cells during embryogenesis, 
inf1ammation, tumor growth, and wound healing. The synthe-
sis, secretion, and deposition of fibronectin in connective tissue 
matrices is probably an important mechanism by which paren-
chymal cells directly maintain and/or restore tissue integrity. 
Richard A. F. Clark, M.D. 
National Jewish Hospital 
Denver, Colorado 
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